Keyword Connections

drug

Journals

23

1 Nanoscale

2 Environmental science and pollution research international

3 PloS one

4 Advanced drug delivery reviews

5 Journal of medical Internet research

6 electronic physician

7 optics letters

8 analytica chimica acta

9 journal of clinical medicine

10 journal of computational chemistry

11 medicine and science in sports and exercise

12 journal of pharmaceutical sciences

13 Plants (Basel, Switzerland)

14 annals of surgery

15 current psychiatry reports

16 central nervous system agents in medicinal chemistry

17 international breastfeeding journal

18 european journal of case reports in internal medicine

19 The Review of scientific instruments

20 pharmacy practice

21 the journal of political economy

22 methods in enzymology

23 BMJ (Clinical research ed.)

Research Groups

0

No Research Group Connected

Bibliographies

2524

1 State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies.

2 Linagliptin-Associated Alopecia and Bullous Pemphigoid.

3 Minor Hepatectomies: Focusing a Blurred Picture: Analysis of the Outcome of 4471 Open Resections in Patients Without Cirrhosis.

4 DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1.

5 Opioid Use in Pregnancy.

6 Highly Predictive Genetic Markers Distinguish Drug-Type from Fiber-Type L.

7 Removal of antibiotics from aqueous solutions by nanoparticles: a systematic review and meta-analysis.

8 Measurement of three-dimensional distributions of drugs in nails using liquid chromatography/tandem mass spectrometry after micro-segmentation to elucidate drug uptake routes.

9 Tissue localization of retinoic acid receptor (RAR) active drugs.

10 A Perspective on the Toxicology of Marine Toxins

11 cumulative effect of risk factors on short-term surgical success of mitomycin augmented trabeculectomy.

12 selective serotonin reuptake inhibitors and cardiovascular events: a systematic review

13 the role of ghrelin in anorexia nervosa

14 cathepsin b is a new drug target for traumatic brain injury therapeutics: evidence for e64d as a promising lead drug candidate

15 beta-lactamase escherichia coli and staphylococcus aureus isolated from chickens in nigeria

16 long-term drug use and polypharmacy among the elderly population in the republic of srpska, bosnia and herzegovina

17 educação, prevenção e drogas: resultados e desdobramentos da avaliação de um jogo educativo education, prevention and drugs: results and unfolding of the evaluation of an educational game

18 gynecomastia: clinical evaluation and management

19 Results and Methodological Implications of the Digital Epidemiology of Prescription Drug References Among Twitter Users: Latent Dirichlet Allocation (LDA) Analyses.

20 When I use a word . . . Medical slang: gomers and gomerettes.

21 Drug Trafficking in the Ferizaj region of Kosovo in the period 2018-2022

22 Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources

23 Plasmodium falciparum PFI1625c offers an opportunity to design potent anti-malarials: Biochemical characterization and testing potentials in drug discovery.

24 [Cu(TPMA)(Phen)](ClO): Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity.

25 The potential of chitosan in ocular drug delivery.

26 The use of zein in the controlled release of poorly water-soluble drugs.

27 Synthesis, identification and application of the novel metal-organic framework Fe<inf>3</inf>O<inf>4</inf>@PAA@ZIF-8 for the drug delivery of ciprofloxacin and investigation of antibacterial activity

28 Synthesis, characterization and crystal structure of a new organic salt of antidiabetic drug metformin resulting from a proton transfer reaction

29 Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance.

30 Toward Rational Design of Novel Anti-Cancer Drugs Based on Targeting, Solubility, and Bioavailability Exemplified by 1,3,4-Thiadiazole Derivatives Synthesized Under Solvent-Free Conditions.

31 Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations.

32 Linker Optimization and Therapeutic Evaluation of Phosphatidylserine-Targeting Zinc Dipicolylamine-based Drug Conjugates.

33 Pyocyanin, a Metabolite of Pseudomonas Aeruginosa, Exhibits Antifungal Drug Activity Through Inhibition of a Pleiotropic Drug Resistance Subfamily FgABC3.

34 Self-emulsifying drug delivery systems: In vivo evaluation of their potential for oral vaccination.

35 Facile synthesis of chitosan-grafted beta-cyclodextrin for stimuli-responsive drug delivery.

36 Biocompatible carbon dots derived from κ-carrageenan and phenyl boronic acid for dual modality sensing platform of sugar and its anti-diabetic drug release behavior.

37 Substituent dependent sensing behavior of Schiff base chemosensors in detecting Zn<sup>2+</sup>and Al<sup>3+</sup> ions: Drug sample analysis and living cell imaging

38 Biological Significance of Imidazole-Based Analogues in New Drug Development.

39 Correlating anticancer drug delivery with vascular permeability of nanocarriers: renal clearable vs. non-renal clearable ones.

40 Epirubicin-loaded marine carrageenan oligosaccharide capped gold nanoparticle system for pH-triggered anticancer drug release

41 Multifunctional Gold Nanoparticles Overcome MicroRNA Regulatory Network Mediated-Multidrug Resistant Leukemia

42 Artificial Intelligence: A Novel Approach for Drug Discovery.

43 Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.

44 Non-steroidal Anti-inflammatory Drugs in Tonic, Phasic and Inflammatory Mouse Models.

45 A modified zeolite/iron oxide composite as a sorbent for magnetic dispersive solid-phase extraction for the preconcentration of nonsteroidal anti-inflammatory drugs in water and urine samples.

46 Sustained Local Delivery of Diclofenac from Three-Dimensional Ultrafine Fibrous Protein Scaffolds with Ultrahigh Drug Loading Capacity.

47 Blend of cellulose ester and enteric polymers for delayed and enteric coating of core tablets of hydrophilic and hydrophobic drugs.

48 Topological and electrostatic properties of diclofenac molecule as a non-steroidal anti-inflammatory drug: An experimental and theoretical study

49 Preconcentration and sensitive determination of the anti-inflammatory drug diclofenac on a paper-based electroanalytical platform

50 Investigation of molecular interactions of the drug Diclofenac Sodium Salt in water and aqueous sorbitol systems at different temperatures (305.15 K–315.15 K)

51 Balancing stealth and echogenic properties in an ultrasound contrast agent with drug delivery potential.

52 A hollow mesoporous carbon from metal-organic framework for robust adsorbability of ibuprofen drug in water.

53 Effects of food type on the extent of drug-drug interactions between activated charcoal and phenobarbital in rats.

54 Hydrogen sulphide: novel opportunity for drug discovery.

55 Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.

56 Like Dissolves Like? A Comprehensive Evaluation of Partial Solubility Parameters to Predict Polymer-Drug Compatibility in Ultrahigh Drug-Loaded Polymer Micelles.

57 A PEGylated alternating copolymer with oxidation-sensitive phenylboronic ester pendants for anticancer drug delivery.

58 Ultrasound assisted-phytofabricated Fe<inf>3</inf>O<inf>4</inf> NPs with antioxidant properties and antibacterial effects on growth, biofilm formation, and spreading ability of multidrug resistant bacteria

59 How to Develop a Drug Target Ontology: KNowledge Acquisition and Representation Methodology (KNARM).

60 An Unexpected Degradation Pathway of a 1,2,4-Triazolo[4,3-a]pyridine Derivative: The Formation of 2 Cationic Pseudodimers of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Drug Candidate in a Stressed Capsule Formulation.

61 Emerging roles of exosomal miRNAs in breast cancer drug resistance.

62 Modeling molecular interactions of propounded pyrazole based drug candidates against bacterial DNA gyrase: Validation by syntheses and biological studies

63 Re: Letter to editor: heart rate effects of antimuscarinic drugs.

64 Capsaicinoids enhance chemosensitivity to chemotherapeutic drugs.

65 Treatment Emergent Violence To Self And Others; A Literature Review of Neuropsychiatric Adverse Reactions For Antidepressant And Neuroleptic Psychiatric Drugs And General Medications.

66 Inhibition activity prediction for a dataset of candidates' drug by combining fuzzy logic with MLR/ANN QSAR models.

67 Detecting adverse drug reactions in discharge summaries of electronic medical records using Readpeer.

68 iGPCR-drug: a web server for predicting interaction between GPCRs and drugs in cellular networking.

69 Exposure to anti-malarial drugs and monitoring of adverse drug reactions using toll-free mobile phone calls in private retail sector in Sagamu, Nigeria: implications for pharmacovigilance

70 Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population.

71 Identification of Potential Drug-targets by Combining Evolutionary Information Extracted from Frequency Profiles and Molecular Topological Structures.

72 Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007-2016.

73 Comparison of zebrafish larvae and hiPSC cardiomyocytes for predicting drug induced cardiotoxicity in humans.

74 Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast Cancer.

75 Long-term Engineered Cultures of Primary Mouse Hepatocytes for Strain and Species Comparison Studies During Drug Development.

76 Cost drain of anesthesia emergency drugs in a quaternary care hospital.

77 Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data

78 Payments from drug companies to physicians are associated with higher volume and more expensive opioid analgesic prescribing

79 Seven expensive drugs classified for sluice

80 MS drugs: Expensive, often lifelong, and not cost effective

81 Money-Back guarantees for expensive drugs: Wolf's clothing but a sheep underneath

82 Issues and difficulties of the management of expensive drugs not included in the list in addition for a hospital dealing with cancers

83 Why are new drugs so expensive?

84 Ethical issue in use of expensive drugs for treatment of rare metabolic diseases in Hong Kong

85 Health economist Marc Pomp: Predicting costs is a feat. Horizon scan of expensive drugs is 'incomplete overestimation'

86 Serious doubts about expensive anticancer drugs

87 Drugs: New drugs will become more expensive

88 US drug maker sues to force Ireland to offer expensive Duchenne's treatment

89 Program to manage new and expensive drugs in pediatrics: Profile of a new drug policy and a 12-month descriptive study

90 Switching expensive drugs with frequently diminishing value

91 Orphan Drugs: Way Too Many, Way Too Expensive

92 Discussing and prescribing expensive unfunded anticancer drugs in Australia

93 Accelerated approval and expensive drugs - A challenging combination

94 How expensive may drugs be? The example of hepatitis C drugs

95 How should therapeutic decisions about expensive drugs be made in imperfect environments?

96 Pediatric drugs - good but too expensive: Appeal to the FDA and the manufacturers

97 What makes an essential medicine? WHO's new list focuses on antibiotic resistance, adds expensive drugs, and downgrades Tamiflu

98 To reimburse or not? Evaluating expensive drugs differently

99 Copay assistance for expensive drugs: A helping hand that raises costs

100 A Novel ZnO Nanoparticle as Drug Nanocarrier in Therapeutic applications: Kinetic Models and Error Analysis

101 A Novel ZnO Nanoparticle as Drug Nanocarrier in Therapeutic applications: Kinetic Models and Error Analysis